Current Location:
> This Story

starstarstarstarempty star (1)
Log in or Register to rate this News Story
Forward Printable StoryPrint Send us your Comments

Never Miss a Story

Sign up for email alerts


More Industry Headlines

UCLA not responsible for patient record release, could set legal precedent Doctors sharing access against facility rules not fault of institution

Texas MakerHealth Space will facilitate the creation of care solutions by nurses Providing tools from 3-D printers to Velcro

International institutions agree on standard for using MR to diagnose prostate cancer Cuts overdiagnosis by 89 percent

Siemens Healthcare selects David Pacitti as new head of North America business Pacitti will take over the position on October 19

Konica Minolta acquires Viztek Cites primary imaging solutions that provide more economic value as incentive to completing deal

228 lawmakers urge Congress to rethink proposed cuts to radiation therapy Prostate, breast could be cut by 25 and 19 percent respectively

Philips and MIT collaborate on better way to evaluate brain injuries Bringing the measurement of intracranial pressure out of the ICU

New wearable “e-patch” cuts health monitoring costs, improves quality Up to eight vital signs in a $10 disposable patch the size of a credit card

Annual mammo screening should start at 40, ACR reiterates Recognizing the benefits is critical to saving lives

Planned Dallas Proton Treatment Center files for Chapter 11 bankruptcy Billionaire investor is calling for new project leadership

Regenerative medicine
to generate sales

Regenerative Medicine to Be a $20 Billion Industry by 2025

by Brendon Nafziger , DOTmed News Associate Editor
Explosive growth over the next decade in the field of regenerative medicine could aid medical device companies looking to develop "delivery systems" for cell therapies, according to an analysis released last week.

The market for technologies that repair the body now stands at $1.6 billion, but could swell to $15-20 billion over the next 15 years, says Arshad Ahmed, partner of Scientia Advisors, a biotech and medical consulting firm, in a global market review.

Story Continues Below Advertisement

qualiTEE - reliabiliTEE - repairabiliTEE - we guaranTEE

Bayer HealthCare Multi Vendor Service will repair your probe with the same precision and care you provide to your patients. Call us at 1-844-MVS-5100 (1-844-687-5100) or visit

While regenerative medicine conjures up mad-science images of growing batches of new organs or limbs - or even the infamous mouse with a human ear blooming on its back - the main focus of "regen" in the short-term will be on practical, specific clinical applications, Ahmed tells DOTmed News.

What these therapies might lack in sci-fi glamor, they make up for in potential clinical benefits to patients and time-saving in physicians' workflows.

For instance, currently, half of the revenues of regen comes from spine fusion applications, such as those supplied by Medtronic, says Ahmed.

These involve bone morphogenetic protein, or BMP, genetically modified human proteins that spur bone growth. It's delivered in a sponge or gel, and helps vertebrae fuse back together after certain kinds of spine surgeries.

Ahmed believes that BMP is a good model for future successful regen products, because it makes doctors' "workflow much simpler than the existing standard of care," he says.

BMP is only approved for some kinds of spinal fusion surgeries and a study last year suggested it was associated with a higher rate of complications. Still, Ahmed points out that it has been widely adopted by surgeons, because it has the potential to make "life much easier" by reducing the number of procedures performed in a back surgery.

For surgeries where doctors can use BMP, they can forgo the usual first step of removing a piece of the patient's hip bone, which they then have to grind to a powder and then re-inject into the patient's spinal cage during the surgery, to encourage healing - a role now taken over by BMP.

"The procedure is simpler and it takes less time for surgeons to do it, so they can see more patients," he says.

Patients like it, too, he notes, as they're spared an extra surgical step.


Over the short-term, Ahmed expects much of the new growth to be in peripheral vascular applications, where regen is helping the body repair damage to the vascular system.

One promising treatment possibly not too far from the clinic is being developed by Pervasis.

Continue reading Regenerative Medicine to Be a $20 Billion Industry by 2025...
  Pages: 1 - 2 - 3 >>


Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to, Inc. Copyright ©2001-2015, Inc.